MDMA works with the Centers for Medicare and Medicaid Services (CMS), Congress, private payers, and other stakeholders to promote reimbursement policies for government health care programs and private payers that support timely and adequate access for patients to innovative medical technologies. This includes policies related to coverage determinations, coding, payment setting, claims processing, and other reimbursement issues. The collaborative input of members informs MDMA’s proactive and reactive policy development efforts, including analysis of reimbursement-related legislation and the drafting of comments submitted on annual Medicare payment system updates and other proposed rules.